Page 287 - 16Neonatal Jaundice_compressed
P. 287

Neonatal jaundice


 Bibliographic details   Study type &   Patient characteristics   Test, Reference Standard,   Results   Reviewers Comments
 Evidence level   Threshold for a positive test
 Gender: Males = 50%      SD = Not reported

 Prevalence of TSB >   Diagnostic accuracy of TcB (threshold value
 250 micromol/litre = 55/300 (18.3%)   > 195 micromol/litre) for detecting TSB >
                250 micromol/litre
 Exclusion: babies who had previously
 received phototherapy   Sensitivity: 50/55 (90.9%)
                Specificity: 162/245 (66.1%)
                PPV: 50/133 (37.6%)
                NPV: 162/167 (97%)

 Briscoe L;   Study Type:   Babies > 34 weeks who were having   TcB reading using Minolta JM-102   Correlation of JM-102 with lab TSB levels   Unselected population
    Diagnostic study   blood taken for any reason, mostly   at the forehead   (Pearson correlation coefficient, n = 303)   Test & Reference test described
 Year: 2002      done for clinical jaundice.   (mean of 3 readings used for      in detail
    Evidence Level: II      analysis)   r = 0.76, P < 0.0001   Test and reference test carried
 Country:      n = 303                         out within one hour
 UK      median BW 3267 g - range 1800–  Reference standard: Laboratory   Diagnostic accuracy of JM-102 for detecting   Blinding – not specified
    5008   TSB levels measured concurrently   TSB > 249 micromol/litre (n = 303)   Data not extractable for
 46    median GA 39 weeks - range 34–42         calculating values of TP, FP,
    median age at presentation: 3 – range   For diagnostic accuracy:   Area under ROC = 0.89   TN & FN
    0 to 13 days   Area under ROC curve calculated
 Gender: Not reported   for detecting TSB   Predictive accuracy of JM-102 value 19.9
    > 249 micromol/litre   (highest accuracy from ROC curve)
 Ethnicity
 White: 94.7%      Sensitivity: 86% (81–89%)
                Specificity: 78% (73–83%)
                PPV: Not reported
 Prevalence of TSB >   NPV: Not reported
 300 micromol/litre = 3.3% (10/303)

 Exclusion: babies who had previously   In this study a reading of > 18 reflectance
                units was taken as an indicator for serum
 received phototherapy   bilirubin, resulting in a reduction of 34% in
                the number of blood samples taken.

 Bhutani VK;   Study Type:   All babies born from 01 January 1990   Incremental hospital systems   Incidence of adverse outcomes for term and   Non-comparative observational
    Observational study   to 31 December 2000 who were   approach in the management of   near-term infants in the well-baby nursery   study
 Year: 2006      discharged from the well-baby   neonatal hyperbilirubinaemia   Hospital-based intensive phototherapy   Time periods of different
    Evidence Level: III   nursery of a tertiary hospital as term   studied with different clinical   Phase 1: 3.6%   clinical approaches
 Country: USA      and near-term healthy babies.   approaches at different phases:   Phase 2: 4.5%   overlapping. Confounding
          Phase 1:   Phase 3: 5.4%             variables not adjusted
 47    n = 31 059   selective pre-discharge TSB   Phase 4: 2.5%
    mean BW: 3318 ± 457 g mean GA:   measurements (1990–1992)   Phase 5: 1.3%
    Phase 2:
 38.7 ± 1.3 weeks   universal TSB measurement at the   Exchange transfusion
 Gender: Males = Not reported   time of metabolic screening with an   (in risk)
    authority given to nurses (after in-  Phase 1: 1:2137
 Ethnicity:   service workshops and training) to   Phase 2: 1:1322
 White = 43.5%   obtain bilirubin estimation at their   Phase 3: 1:1637



 216
   282   283   284   285   286   287   288   289   290   291   292